Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People's Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia (AGA) and acne vulgaris, which is in phase III clinical trial; and GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris that is in phase II clinical trial. The company is devel...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 51 2626 39909
Address:
Suzhou Industrial Park, No.20 Songbei Road China (Jiangsu) Pilot Free Trade, Suzhou, China
